Cargando…

Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era

Target-oriented agents improve metastatic colorectal cancer (mCRC) survival in combination with chemotherapy. However, the majority of patients experience disease progression after first-line treatment and are eligible for second-line approaches. In such a context, antiangiogenic and anti-Epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Guido, Parcesepe, Pietro, Bruno, Giuseppina, Piscazzi, Annamaria, Lizzi, Vincenzo, Remo, Andrea, Pancione, Massimo, D’Andrea, Mario Rosario, De Santis, Elena, Coppola, Luigi, Pietrafesa, Michele, Fersini, Alberto, Ambrosi, Antonio, Landriscina, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307359/ https://www.ncbi.nlm.nih.gov/pubmed/34299337 http://dx.doi.org/10.3390/ijms22147717

Ejemplares similares

Molecular and Clinical Insights in Malignant Brenner Tumor of the Testis With Liver Metastases:A Case Report
por: Parcesepe, Pietro, et al.
Publicado: (2021)

IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
por: Crispo, Fabiana, et al.
Publicado: (2020)

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
por: Giordano, Guido, et al.
Publicado: (2017)

Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancer
por: Caruso, Francesca Pia, et al.
Publicado: (2022)

Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer
por: Giordano, Guido, et al.
Publicado: (2023)

Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines
por: Piscazzi, Annamaria, et al.
Publicado: (2022)

TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation
por: Bruno, Giuseppina, et al.
Publicado: (2022)

TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)
por: Landriscina, Matteo, et al.
Publicado: (2010)

Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate
por: D’Andrea, Mario Rosario, et al.
Publicado: (2021)

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
por: Leone, Augusto, et al.
Publicado: (2022)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma
por: Lacedonia, Donato, et al.
Publicado: (2021)

Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines
por: Lepore, Silvia, et al.
Publicado: (2020)

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
por: Giordano, Guido, et al.
Publicado: (2014)

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
por: Parente, Paola, et al.
Publicado: (2018)

Immune Resistance and EGFR Antagonists in Colorectal Cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
por: Parcesepe, Pietro, et al.
Publicado: (2016)

TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas
por: Maddalena, Francesca, et al.
Publicado: (2020)

Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression
por: Pancione, Massimo, et al.
Publicado: (2012)

Haemostasis in Thyroid Surgery: Collagen-Fibrinogen-Thrombin Patch versus Cellulose Gauze—Our Experience
por: Tartaglia, Nicola, et al.
Publicado: (2016)

DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment
por: Villani, Rosanna, et al.
Publicado: (2016)

A Rare Case of Functioning Adrenocortical Oncocytoma Presenting as Cushing Syndrome
por: Tartaglia, Nicola, et al.
Publicado: (2016)

Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review
por: Cianci, Pasquale, et al.
Publicado: (2015)

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2015)

Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process
por: Pancione, Massimo, et al.
Publicado: (2021)

Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer
por: Remo, Andrea, et al.
Publicado: (2015)

Spleen assessment after laparoscopic transperitoneal left adrenalectomy: preliminary results
por: Cianci, Pasquale, et al.
Publicado: (2015)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
por: Pancione, Massimo, et al.
Publicado: (2014)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: A novel strategy for human BRAF-driven colorectal carcinoma
por: Condelli, Valentina, et al.
Publicado: (2015)

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
por: Remo, Andrea, et al.
Publicado: (2015)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance
por: Sisinni, Lorenza, et al.
Publicado: (2019)

A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study
por: Matsuda, Akihisa, et al.
Publicado: (2022)

Proteins pattern alteration in AZT-treated K562 cells detected by two-dimensional gel electrophoresis and peptide mass fingerprinting
por: D'Andrea, Gabriele, et al.
Publicado: (2006)

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes
por: Remo, Andrea, et al.
Publicado: (2019)

Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures
por: Floridi, Chiara, et al.
Publicado: (2022)

The era of precision oncogenomics
por: Carpten, John C., et al.
Publicado: (2018)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
por: Crispo, Fabiana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tal915roc9693su80avnht16ia